Case Presentations
CASE I:

A 43-year-old white male construction worker was admitted to the coronary care unit for evaluation of
left anterior chest discomfort.
How would you manage the following intermittent arrhythmia, which was noted shortly after admission?
Vital signs remained stable.
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CASE I

Dr. Baird: Dr. Dreifus, how would you manage this
patient's arrhythmia?
Dr. Dreifus: You have here a premature ventricular
systole which begins a run of slow ectopic beating
presumably from the ventricle. It is not occurring on
top of the T wave. The victim is in ventricular tachycardia at a rate of about 60 or 62, and it appears to
be a slow ventricular idioventricular rate without retrograde P waves. In this case I would try speeding up
the sinus rate with a little atropine to eliminate the
slow rate.
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Dr. Baird: Would any other panelists like to comment
or disagree?
Dr. Zoll: I would simply watch the patient and do
nothing else.
Dr. Parsonnet: In our coronary care unit with continuous monitoring, this is not an infrequent arrhythmia, though Dr. Samet has just whispered in my ear
that he sees it rarely in his unit. It is totally benign
and has no serious consequences, therefore it is not
treated.
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CASE PRESENTA TIONS
CASE II:

This 75-year-old black male represents an arrhythmia related to digitalis toxicity.
Is temporary pacing indicated?

CASE II

Dr. Baird: This is a frequent problem in city hospitals.
There is no adequate history available on this patient,
but apparently he has been taking too much digitalis.
The question is, if he has atrial fibrillation with highdegree A-V block, how would you manage him during
the interim period?
Dr. Samet: First, how symptomatic is this individual?
Dr. Baird: He is confused, and he has been nauseated,
but there has been no evidence of Stokes-Adams
seizures. He has mild congestive failure.
Dr. Samet: Well, the rate here is in the low 40's. If he
is symptomatic with something that would be improved by increased rate, then I would pace him. If
he is not symptomatic with this arrhythmia, and if I
felt it was due to digitalis, I would not pace, but stop
the digitalis and just watch him. One point I want to
stress is that when high-degree A-V block is a manifestation of digitalis toxicity, the administration of
potassium is inappropriate and may have untoward
consequences. If this is just complete heart block, then
the potassium may have no further block-producing
tendencies.
Dr. Baird: How do the other panelists feel? Dr. Dreifus,
are you concerned about pacing a patient who has an
arrhythmi a due to digitalis?
Dr. Dreifus: I think if he is confused, I would do as
Dr. Samet stated . The question is whether or not he is
symptomatic. Now there is some controversy over
potassium. I would tend to agree that if in the sub-
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junctional regions you give enough potassium or give
it too fast, you will cause further block. However,
there is no doubt that potassium will antagonize digitalis in the N region of the A-V node and increase
conduction. If the serum potassium were depressed
and if I were worrying about causing further depression, I would then pace the patient and still administer
potassium.
Dr. Baird: Thank you. What are the hazards with
temporary pacing in patients with digitalis-induced
arrhythmia? What has been your experience in this
situation?
Dr. Dreifus: What you are worried about is the mechanical stimulation of that catheter number 1 and 2.
If you induce a propagated response from the pacemaker on top of T wave in an over-digitalized patient,
is the ventricle more vulnerable? Yes, the ventricle is
more vulnerable, and the risk is increased. But with
proper placement and prophylactic use of agents while
you are passing the catheter and with great skill and
few premature ventricular beats, this is really not a
problem.
Questioner: What is your attitude toward treating this
patient with diphenylhydantoin?
Dr. Dreifus: I don't think diphenylhydantoin would be
of value in this instance. In the concentrations used
clinically, we have shown that it increases block in the
A-V node. If there were ectopic ventricular beats with
block here, I certainly would avoid drugs and go the
pacing route.

CASE PRESENTATIONS
CASE Ill:
This patient with a permanent pacemaker developed substernal pain and hypotension.
Would sympathomimetic amines be helpful to restore his blood pressure?

CASE Ill

Dr. Baird: Dr. Zoll, how do you feel about the concomitant use of sympathomimetic amines in patients
with pacemakers?
Dr. Zoll: With the functioning permanent pacemaker
in place, one would treat hypotension with drugs as if
the patient were in normal sinus rhythm. As long as
the pacemaker rate is reasonably rapid, as in this case,
the appropriate vasoconstrictor agents (i.e., neosynephrine or isoproterenol) can be used. Most of these
drugs do have a tendency to arouse ectopic activity as
well as acceleration of dominant rhythm; however,
with a well-functioning pacemaker, a positive inotropic
action is not immediately seen.
Dr. Samet: My first reaction after seeing this tracing
would be to ask for other leads. While this tracing
probably represents paced beats followed by a T wave,
I am not mathematically certain whether or not these
other beats represent premature beats. I would have
to see other leads in order to be certain.
Dr. Baird: I have used this case to suggest that in certain patients sympathomimetic amines might lower the
threshold for ventricular fibrillation, and there might
be instances in which untoward administration of these
drugs might precipitate ventricular tachyrhythmias.
Anybody have any comments or experience with this
situation? Dr. Dreifus?
Dr. Dreifus: Yes. I learned my lesson on the cardiac
surgery table where we used a good deal of sympathomimetic amines, particularly isoproterenol. Beyond a flow of 3 micrograms per minute of isoproterenol, you will get increased ectopic beating that
could be fatal to the patient. Therefore, it is a matter
of degree how you use these agents. I don't think we
can say that they are all good or all bad; we should,
however, be aware of the dangers and the limitations
of administration.

Dr. Zoll: Isoproterenol clearly does arouse and accelerate ventricular pacemakers. There is a definite
risk with isoproterenol; but if one gives the drug in a
diluted solution, say 1 or 2 micrograms per minute,
we can then step it up every several minutes. We
usually change the dose every 4 or 5 minutes, watching what is going on all the time. You can keep on
going until you get either the desired therapeutic effect
of an increased cardiac output or increased blood pressure. If untoward effects appear (i.e., ectopic beats),
reduce the dosage or adjust the administration of the
dosage until no adverse effects are seen. There is no
real limit as to how much you should give a patient.
We have given over 30 micrograms per minute of
isoproterenol to some patients with complete heart
block, in what I consider to be a safe and effective
way. On the other hand, some patients might run into
trouble with a much smaller dose, in which case you
stop and take care of the situation accordingly.
Dr. Samet: The arrhythmic effects of the vasoconstrictors really have two aspects. One is the direct aspect
which has been alluded to, and the other is an aspect
which follows the development of hypertension. That
is, when one gets the desired effect by overshooting
the mark, reflex arrhythmias secondary to hypertension can develop. Which leads me to my next point:
One of the things we have learned to mistrust is the
peripheral arterial pressure under these circumstances.
We have, in a number of instances, obtained hypotensive readings with the usual blood pressure determination. Because you can readily overshoot the mark,
we prefer monitoring the arterial pressure interarterially almost routinely when we feel we have to administer vasopressors. So I warn you not to trust the
routinely determined blood pressures in these hypotensive patients.
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CASE PRESENTATIONS
CASE IV:

This 70-year-old white male was admitted for hematologic evaluation when he suddenly developed chest pain
and acute EKG changes suggestive of diaphragmatic myocardial infarction. Several days later, he was placed
on oral procainamide to suppress VPC's. However, the following arrhythmia developed.

CASE IV

Dr. Baird: Dr. Narula, how would you manage the
patient in this situation?
Dr. Narula: This looks to be a very interesting arrhythmia which terminated spontaneously. Because of
the sudden sinus beat, the possibility of fusion beat is
less likely. Therefore, I would say it is probably
another ectopic beat which suppresses the ventricular
tachyrhythmias and gives the sinus rhythm a chance.
Dr. Baird: You would give more suppressant drug
therapy?
Dr. Narula: Because sinus rhythm is fairly stable in
this patient, within the normal physiological range, I
think this patient would require suppressant therapy.
Dr. Baird: Any other comments?
Dr. Samet: In this discussion about the treatment of
cardiac arrest and ventricular arrhythmia, I would
like to stress that Dr. Zoll and I were just talking
about a very simple physical mode which does really
work; we have seen a blow on the chest administered
by a clinched fist stop ventricular fibrillation; we have
also seen it restart the heart that was arrested in just
a few seconds.
Dr. Parsonnet: I would like to add that as far as
therapy in the cardiac care unit is concerned, there is
a tendency to worry about the electrocardiogram and
forget about the other things happening to the patient.
For example, a person who has been in the intensive
care unit for a few days, hypoventilating and getting
all kinds of drugs, may have serious abnormalities in
their blood gases and blood electrolytes. Before you
rush off and start using a lot of other things, I think
you ought to make sure that you have a normal

electrolyte bala nce. Sometimes, by simply directing the
blood gases or blood electrolytes, you can stop the
arrhythmias.
Dr. Dreifus: I agree with Dr. Parsonnet; you have to
look for other problems. But remember, these ventricular premature beats are bisecting the T wave. In
other words, the onset is very close to the T wave, and
vasoconstrictors will respond to drugs like lidocaine
and procainamide. This repeated occurance in the
development of fibrillation brings up an interesting
hiatus in drug therapy: Do we use a drug like procainamide or lidocaine, which actually decreases fibrillation threshold, or do we switch to an agent like
bretylium? We just might end up treating these arrhythmias with bretylium when they are prefibrillatory
or fibrillatory. If there are single ventricular premature
systoles, you may take the lidocaine approach first just
to get rid of the ectopic beating period. However, if
they are prefibrillatory, as in this particul ar record, we
may be using bretylium in the future . I think you had
better keep a very close eye on the literature to see
where we go from here.
Dr. Baird: Dr. Samet, do you agree with Dr. Dreifus's
enthusiasm in regard to bretylium?
Dr. Samet: If we are talking about bretylium as a drug
of initial approach, I do not agree. However, if we are
talking about bretylium as a drug to be used when
others have failed, then I agree emphatically. There
are side effects with bretylium even in the horizontal
position which does not make it the drug of initial
choice. We still rely upon lidocaine, quinidine, procainamide, etc., but have used bretylium with success on
a number of occasions. The role of bretylium has to be

CASE PRESENTATIONS
kept in proper perspective.
Dr. Richardson: What about procainamide as an inciting drug?
Dr. Baird: Well, that's a point I was trying to emphasize. Dr. Dreifus, when ventricular tachyrhythmias
revert spontaneously, doesn't this give you a clue that
quinidine or procainamide was induced?
Dr. Dreifus: No.
Dr. Baird: D o any of the panelists have experience
with recurrent ventricular fibrillation due to quinidine?
Our experience is, in a limited number of cases, that
they do not require defibrillation, but m ay be controlled with overdrive pacing.
Dr. Samet: Would you tell us a little more about the
circumstances developed? I suspect that some of those

cases do not represent quinidine sensitivity but inappropriate use of quinidine.
Dr. Baird: That is an important point in determining
whether it is really a toxic effect, a rate-dependent
problem, or an effect related to a true sensitivity as
originally described; but this a point of argument. The
procainamide was stopped and the patient's ventricular irritability decreased. He did not require any overdrive pacing as a technique suppressing drug-induced
recurrent ventricular tachyrhythmias.
Dr. Narula: Could it be that the chest pains and the
ischemic changes disappeared with time and were responsible for the disappearance of the arrhythmia
rather than the discontinuance of the procainamide?
Dr. Baird: No.

CASE V:
A 2V2-year-old child was in excellent health until he developed a viral illness, which was complicated by
rapid heart rate. Initial therapy was digitalization to control "PAT." This failed and recurrent bouts of
"VT" required 350 countershocks ( 100-200 W.S.).
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CASE PRESENTATIONS
CASE V

Dr. Baird: Here we discuss the advantages and disadvantages of pacing. I have just mentioned the fact
that atrial overdrive for ventricular pacing may control
a certain arrhythmia. In this case the child, who had
been in excellent health, developed a flu-like syndrome
associated with recurrent bouts of tachyrhythmia.
At first it was thought that these were paraoxysmal
atrial tachycardia. However, an intra-atrial lead demonstrated clearly dissociation between the atrial activity and the ventricular rhythm disturbance. The diagnosis was made that this was recurrent ventricular
tachycardia in a child who possibly had some type of
myocarditis or myocardiopathy. Assuming the diagnosis is correct, what would you recommend in the
way of pacing or drugs to control this particular problem? The child had been given 350 countershocks by
the pediatric service for recurrent bouts of ventricular
tachycardia associated with hypotension. Dr. Dreifus,
what are your thoughts on this problem?
Dr. Dreifus: Obviously this is a very difficult situation.
I have not seen ventricular tachycardia very often in
children. The use of digitalis here is contraindicated
under the circumstances. I am not at all convinced
that this is ventricular tachycardia. It could be junctional with aberrant conduction. Atrial pacing might
work in this case if you could get the catheter to stay
in place, but that is tough in a kid. Ventricular pacing
may also work, but that too is difficult. What I have
dealt with in children is the use of propranolol and
quinidine. The problem is getting them to take that
combination because it tastes terrible. But sometimes
that will control the ventricular tachycardia. I have
not used bretylium, but I think that if I had my choice
after all the electricity that has passed through this
kid, I might say this is one of the prefibrillatory or
prerepetitive situations and switch to a drug like
bretylium rather than push my luck with the other
depressant agents.
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Dr. Baird: Before we comment on bretylium, do you
think there is any clinical trial justification of internal
defibrillation?
Dr. Dreifus: I don't know that we could do it in a
child though we do it in dogs. It takes a lot of hardware, and I am wondering if it would really be practical in the end. It works, but maybe Mr. Berkovits
will have some ideas on how to develop the electronics
to improve it. I would try to solve all problems like
this pharmacologically rather than on an internal or
external defibrillation basis. Once the patients are put
on a prophylactic pharmacological treatment, the arrythmia usually goes away.
Dr. Baird: Any other comments? After bretylium was
administered intravenously in this child, acceleration
of the ventricular rate occurred. Whether continued
ad ministration of bretylium would have been effective
as an antiarrhythmia, I don't know. After I had caused
rate acceleration with the drug, I was no longer asked
to follow the patient. Dr. Dreifus?
Dr. Dreifus: Small doses of bretylium do have a tendency to aggravate the arrhythmia. There is no doubt
about it. There are some electrophysiological reasons
why this might occur. The trick is to use enough, but
using bretylium in a kid for a rather unknown problem is risky. You may have been right to back off. I
might have tried a large dose.
Dr. Baird: It has been an enjoyable day and a half.
I would like to acknowledge the moderators, Drs.
Richardson* and Drew * as well as the panelists for
the support and advice required to make this a successful program.
* DONALD w. DREW, M.D., Director of Cardiology and
Acting Director of Internal M edicine, Norfolk General
Hospital, Norfolk, Virginia.
* DAVID w. RICHARDSON, M .D. , Professor of Medicine,
The M edical College of Virginia, Richmond, Virginia.

